E-cadherin immunostaining has been used to distinguish lobular and ductal carcinoma in ambiguous cases because ILC is characterized by a decrease in membrane E-cadherin immunohistochemical reactivity when compared with invasive ductal carcinoma. Here, CDH1 is linked to breast ductal adenocarcinoma.